Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Sprague Dawley Rag2-Null Rats Created from Engineered Spermatogonial Stem Cells Are Immunodeficient and Permissive to Human Xenografts.

Noto FK, Adjan-Steffey V, Tong M, Ravichandran K, Zhang W, Arey A, McClain CB, Ostertag E, Mazhar S, Sangodkar J, DiFeo A, Crawford J, Narla G, Jamling TY.

Mol Cancer Ther. 2018 Nov;17(11):2481-2489. doi: 10.1158/1535-7163.MCT-18-0156. Epub 2018 Sep 11.

PMID:
30206106
2.

In a safety net population HPV4 vaccine adherence worsens as BMI increases.

Harper DM, Else BM, Bartley MJ, Arey AM, Barnett AL, Rosemergey BE, Paynter CA, Verdenius I, Harper SM, Harris GD, Groner JA, Malnar GJ, Wall J, Bonham AJ.

PLoS One. 2014 Jul 30;9(7):e103172. doi: 10.1371/journal.pone.0103172. eCollection 2014.

3.

The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series.

Harper DM, Verdenius I, Harris GD, Barnett AL, Rosemergey BE, Arey AM, Wall J, Malnar GJ.

Prev Med. 2014 Apr;61:20-5. doi: 10.1016/j.ypmed.2014.01.007. Epub 2014 Jan 15.

PMID:
24440159
4.

Quantifying clinical HPV4 dose inefficiencies in a safety net population.

Harper DM, Verdenius I, Ratnaraj F, Arey AM, Rosemergey B, Malnar GJ, Wall J.

PLoS One. 2013 Nov 6;8(11):e77961. doi: 10.1371/journal.pone.0077961. eCollection 2013.

Supplemental Content

Support Center